Introduction
Mastitis is the most important health problem in bovine dairy herds. Multifarious microorganisms have been implicated as causative agents of bovine mastitis, including bacteria and fungi (1) . Fungal infections of the mammary gland are mostly caused by yeast, the main genus of which is Candida (2) . Mastitis infections caused by fungi of the genus Candida have long been known in animals and Fleischer was presumably the first researcher to describe a case of mycotic mastitis in 1930 (3) .
The prevalence of mycotic mastitis is usually very low as compared to other agents of mastitis, but it has significantly increased during the last decade. Several species of yeast or yeast-like microorganisms have been reported to cause bovine mastitis (4) . Candida, Cryptococcus, Rhodotorula, and Trichosporum have been associated with mastitis in dairy cattle. Intramammal infection caused by fungi as mastitis is usually self-limiting with spontaneous recovery, and the infection generally has no systemic results. Candida species are the most common microorganisms among the mycotic mastitis agents isolated from infected mammary glands (5) . Candida species have been isolated from bovine milk with and without signs of mastitis (6) . Candida is usually the most frequently isolated genus, with great variations in prevalence among herds and identified species (1) .
Recently, rapid identification and molecular biologybased tests have begun to be used more easily and effectively than conventional tests in the identification of fungal pathogens. Diagnostic polymerase chain reaction (PCR) tests have been widely applied in laboratories for identification of many fungal species due to their speed, high sensitivity, and specificity (7). Since PCR was first identified, many modifications of the original procedure have been developed. As with nested PCR, the standard procedure can be made more specific and sensitive with simple modifications. In nested PCR, PCR products are subjected to a second amplification with the second pair of primers located in the middle of the first primers (8) .
The DNA topoisomerase II gene is found in all eukaryotes, and the nucleotide sequence consists of very conserved regions distributed in species-specific regions. Sequence analysis of the DNA topoisomerase II (DNA gyrase) gene in bacterial strains is not only used to determine phylogenetic relationships, but also for the development of diagnostic identification systems for PCR of large bacteria and fungi species with medical importance (9) . In many studies, DNA topoisomerase II gene nucleotide sequences of pathogenic Candida strains have been identified and phylogenetic relationships and characteristics according to nucleotide sequences have been reported (9) (10) (11) .
Fungal mastitis has been described as related to treatment directed against other pathogens using contaminated syringes, cannulas, or contaminated antibiotic preparations. Teat injuries may predispose to establishment of a yeast infection. Yeast intramammary infections have been reported to be responsible for at least 10% of all clinical cases seen in veterinary practice; the majority of cases are usually mild. Although antimycotic drugs have been used for treatment of yeast mastitis, there is no clear evidence of the effectiveness of this therapy (12) . Yeast resistance to antimycotics has been a major problem in recent decades, Candida being the most important pathogenic potential yeast (2) .
The aim of the present study was to identify Candida species by rapid identification tests and nested PCR from milk samples of cows with mastitis, and to determine the antifungal susceptibilities of the species.
Materials and methods

Sample collection
In this study, 260 mastitic milk samples that were collected from 10 different private dairy cattle establishments in Aydın were included. Approximately 20-30 mastitic cattle on each of the 10 dairy farms were sampled and tested for identification of Candida from 2015 to 2016. Mastitis was diagnosed by veterinary practitioners from changes in the udder and milk. Changes in the udder included pain, swelling, warmth, and abnormal appearance of milk (blood-tinged milk, watery secretions, clots, pus). For collection of milk samples, teat ends were cleaned using 70% alcohol moistened swabs and allowed to dry. After discarding the first few streams, 2-5 mL of the milk samples was collected into sterile glass flasks. All milk samples were brought to Adnan Menderes University, Veterinary Faculty, Department of Microbiology laboratory, under cold chain.
The authors of this research hereby declare that collection of specimens was carried out in accordance with the guidelines laid down by the US National Institutes of Health (NIH) regarding the care and use of animals for experimental procedures or with the European Communities Council Directive of 24 November 1986 (86/609/EEC).
Isolation and identification of Candida
Milk samples (100 µL) were inoculated in Sabouraud dextrose broth (Merck 108339) and then incubated at 37 °C for 24 h for the enrichment period. Thereafter, 50 µL of each broth culture was plated on Sabouraud dextrose agar (SDA, Merck 105438) with chloramphenicol (0.05 mg/ mL) and incubated at 37 °C for 24-48 h. After incubation, the isolates were classified to the genus level according to their macroscopic and microscopic morphology (13) . Identification of Candida isolates was carried out using an API 20 C AUX system (bioMérieux, France).
DNA extraction
All identified Candida strains were inoculated on 4% SDA and incubated at 37 °C for 24 h. After that, genomic DNA was isolated with an UltraClean Microbial DNA Isolation Kit (MO BIO Laboratories, Inc., USA) according to the manufacturer's protocol. The genomic DNA was used as template DNA for PCR amplification. Genomic DNA samples were stored in -20 °C deepfreeze until used for PCR.
Primers
PCR primers were designated as CDF28 and CDR148 and were used as common primers for Candida species in the first round of PCR (9, 10) .
The species-specific primers for each of the Candida species were designed to be within the region amplified by the common primer pair. For the design of the speciesspecific primers, the nucleotide sequences of the DNA topoisomerase II genes of Candida species were used (9,10) ( Table 1 ).
All species-specific primers were pooled and designated as PsV, which consisted of 5 species-specific primer pairs. PsV should amplify DNA fragments of 227 bp, 310 bp, 532 bp, 672 bp, and 777 bp corresponding to C. krusei, C. parapsilosis, C. kefyr, C. glabrata, and C. tropicalis, respectively (9,10). 
Standard serotypes
PCR amplifications
Genomic DNA purified from each fungal culture sample was amplified in a reaction mixture (25 µL) containing 12.5 µL of 2X HRM PCR master mix, 9 µL of Milli-Q, 0.75 µL of forward primer CDF28 (5 µM), 0.75 µL of reverse primer CDR148 (5 µM), and 2 µL of template DNA. The concentration of each template DNA was adjusted to 1 pg per PCR tube. The PCR cycle parameters were as follows: preheating at 96 °C for 2 min; then 30 cycles of 96 °C for 30 s, 57 °C for 3 s, and 74 °C for 30 s. PCR products were analyzed using agarose gel electrophoresis on the 1200-bp DNA fragment.
The PCR products generated by the common primers were diluted at a ratio of 1:200 in distilled water and then used as DNA templates for the subsequent nested PCR using PsV. PsV contained 5 primer pairs (10 speciesspecific primers; Table 1 ), each of which was adjusted to 5 µM. With the exception of template DNAs and PCR primers, the nested PCR using PsV was carried out under the same parameters as those of the first round of PCR using the common primers. The reaction mixtures were amplified using a thermal cycler (Mastercycler Personal, Eppendorf Netheler Hinz GmbH, Germany).
Agarose gel electrophoresis
The PCR products were analyzed using agarose gel electrophoresis. The amplified products were electrophoresed in 1.2% agarose gel (Agarose-ME, classic type; Nacalai Tesque, Inc., Japan) with ethidium bromide at 100 V for approximately 45 min. The DNA bands were visualized with a gel documentation system (Infinity VX2, France) and photographed. PCR products were examined for C. krusei (227 bp), C. parapsilosis (310 bp), C. kefyr (532 bp), C. glabrata (672 bp), and C. tropicalis (777 bp).
Antifungal susceptibility testing
Antifungal susceptibility testing of all the yeast isolates was assessed using the agar disk diffusion method as per CLSI guidelines (14) . Mueller-Hinton agar (Merck 105437), pH 7.2, supplemented with 2% glucose and 0.5 µg/mL methylene blue, was utilized as the culture medium. The yeast suspension was adjusted to 1-5 × 10 6 CFU/mL and was seeded onto the surface of the plates. In the present study, the antifungal agents used for the disk diffusion method were amphotericin B (20 µg, BD), ketoconazole (10 µg, BD), miconazole (10 µg, BD), fluconazole (10 µg, BD), flucytosine (1 µg, BD), and nystatin (100 units, BD). To determine whether the isolates were susceptible or had either intermediate resistance or resistance, the above antifungals' zone diameters were compared with the standard zone interpretive break points published in the CLSI M44-A2 guidelines (14) . 
Results
Isolation and identification
In this study, 46 (17.7%) Candida species were isolated from 260 milk samples with mastitis. Based on cultural and morphological characteristics and API 20 C AUX test results, 6 different species of Candida were identified. C. tropicalis was the predominant serotype (26.1%), followed by C. parasilosis (21.7%), C. kefyr and C. krusei (17.4% each), C. rugosa (13%), and C. glabrata (4.4%).
Molecular identification of Candida species
In this study, PCR based on common primers and speciesspecific universal oligonucleotide primers were used to confirm phenotypic identification of Candida species. According to the PCR results, a total of 46 strains were confirmed as Candida sp. by the first round of PCR. Species distribution of Candida isolates (except C. rugosa) was verified with the second round of PCR. Consequently, confirmation of all Candida isolates identified by API 20 C AUX was done by nested PCR. Some of the amplified PCR products are shown in the Figure. 
Antifungal susceptibility
The isolates were found to be susceptible to ketoconazole (78.3%) and resistant to flucytosine (91.3%), amphotericin (82.6%), miconazole and nystatin (73.9%), and fluconazole (69.5%). The susceptibility of Candida species is given in Table 2 . The individual species of isolated Candida spp. showed significant differences in their susceptibility to the drugs used.
Candida kefyr was most sensitive to ketoconazole, miconazole, and fluconazole (100.0%) and nystatin (75% susceptible strains), and resistant to amphotericin and flucytosine (75%).
Candida tropicalis showed susceptibility to ketoconazole (83.3%); intermediate susceptibility to nystatin (83.3%), amphotericin (66.7%), and miconazole and fluconazole (50%); and resistance to flucytosine (83.3%).
Candida glabrata was susceptible to amphotericin (100%), intermediately susceptible to nystatin (100%), and resistant to ketoconazole, miconazole, fluconazole, and flucytosine (100%). Candida parapsilosis was sensitive to ketoconazole (80%), intermediately susceptible to amphotericin and nystatin (100%) and miconazole (60%), and resistant to flucytosine (100%) and fluconazole (80%).
Candida krusei was sensitive to ketoconazole (100%), intermediately sensitive to nystatin (75%), and miconazole (50%), and resistant to fluconazole and flucytosine (100%) and amphotericin (75%).
Candida rugosa was resistant to fluconazole and flucytosine (100%).
Discussion
The prevalence of mastitis related to yeasts is usually low in comparison with other agents of mastitis. However, a high incidence of mycotic mastitis, especially that caused by Candida species, has been noticed recently (15) . Along with the high incidence of fungal infections, an increase in the resistance to antifungal agents was reported (16, 17) .
Presence of Candida spp. in mastitic milks show differences in various parts of the world, e.g., 6 .1% in Egypt (18), 1.3% in Denmark (19) , and 12.08% in Brazil (6). Şeker (20) reported the Candida isolation rate in mastitic milks to be 12.7% in Turkey. In this study, the presence of Candida species in clinical cases of mastitis was determined to be 17.7%. This high incidence rate may be due to the extensive and prolonged use of antibiotics nowadays in Turkey, not only for treatment of mastitis but also as a prophylaxis during the dry periods.
In Turkey, Şeker (20) reported that the most frequently isolated species were C. krusei, C. rugosa, C. kefyr, C. albicans, and C. tropicalis, respectively. Some other studies have had similar results (3, 21, 22) . According to Krukowski et al. (12) , the most frequently isolated species in Poland were C. kefyr, C. cirferi, and C. krusei. In our research, the most frequently isolated species was C. tropicalis (26.1%), followed by C. parapsilosis (21.7%), C. kefyr (17.4%), C. krusei (17.4%), C. rugosa (13%), and C. glabrata (4.4%). C. albicans was not isolated. Simaria and Dholakia (23) and Sukumar and James (24) reported relatively more frequent isolation of C. tropicalis from mastitic udders than other species of Candida. In this study, C. tropicalis was the most frequently isolated yeast from the mastitic milk samples examined. In addition, when the data are examined, the distribution of the Candida percentages and species isolated in cow mastitis varies considerably. This difference is thought to be caused by long-term antibiotic usage or inappropriate hygiene conditions on the farms from which the specimens were collected. In addition, these differences may vary from year to year and may be based on isolation and identification methods.
In our study, we used the API 20 C AUX system, which is a rapid diagnostic test to distinguish Candida species. As indicated by Kanbe et al. (9, 10) , species-level differences were also detected by nested PCR. Both rapid diagnostic tests and PCR results were found to be the same in the study (except for C. rugosa, because primer pairs of C. rugosa could not be provided). When the results were evaluated, it was seen that more accurate and clear results were obtained with nested PCR. However, since nested PCR is more expensive and takes a long time, especially for routine diagnostic laboratories, the rapid diagnostic test kit is more useful.
A very detailed antifungal resistance formation was investigated in this study. The resistance statuses of 6 
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Candida rugosa (n = 6) 2 Candida species against 6 different antifungals are given in Table 2 . According to our results, when all isolates were evaluated, 36 of the 46 strains (78%) were found to be susceptible to ketoconazole, which was the most effective agent against the Candida species. Nystatin was the second most effective antifungal option following ketoconazole in mastitis cases that were due to Candida. According to Wawron et al (25) , nystatin was also the most active antifungal, along with tioconazole. Some of the Candida species are naturally resistant to some antifungals, e.g., there is intrinsic fluconazole resistance in C. krusei. It was shown that many Candida isolates have resistance to amphotericin B. As resistance to flucytosine in C. albicans (10%-30%) is known, increasing resistance in non-albicans Candida species has risen. Natural or acquired resistance to fluconazole was confirmed in C. krusei and C. glabrata (26) . Our findings with C. krusei and C. glabrata supported the literature results.
When the results of this research were evaluated, resistance differences among Candida species to antifungals were demonstrated. Therefore, when Candida species are isolated in cases of mastitis, it is necessary to perform identification for appropriate antifungal selection. For identification, rapid identification tests are useful and not expensive for the routine laboratories. However, especially for scientific research, molecular-based tests involve more precise data.
